Swiss biotech iOnctura has appointed Steven Sciuto as chief financial officer and Michelle Tsai as chief operating officer, ...

Privately-held German drugmaker Grünenthal has acquired commercial rights to erectile dysfunction drug Cialis (tadalafil) in Mexico, Brazil and Colombia from US pharma major Eli Lilly.

Research news last week included Rocket Pharmaceuticals suffering a setback with its Phase II trial of RP-A501, which ...

The US Food and Drug Administration (FDA) has approved mNEXSPIKE (mRNA-1283), a new vaccine against COVID-19, US mRNA ...

Philadelphia-based biotech Vivodyne has raised $40 million in series A funding to advance its fully robotic, AI-powered ...

Japanese drugmaker Astellas Pharma (TYO: 4503) today announced an exclusive license agreement with China’s Evopoint ...

Japanese drugmaker Sumitomo Pharma (TYO: 4506) and Denmark’s Novo Nordisk (NOV: N) have entered into a co-promotion agreement ...

Canadian clinical-stage biotech Zymeworks (Nasdaq: ZYME) today announced that the National Medical Products Administration ...

A typical advertisement for a prescription drug airs on television. The visuals are lively and upbeat; the people are smiling ...

US biotech Regeneron and French drugmaker Sanofi are reviewing next steps for their experimental COPD therapy itepekimab ...

Swiss pharma giant Roche (ROG: SIX) today announced new, 96-week data for fenebrutinib demonstrating that patients with ...

Shares in US biotech Intellia Therapeutics (Nasdaq: NTLA) slid by a quarter on Thursday following a safety update from its ...